Ca2+-Handling Proteins and Heart Failure: Novel Molecular Targets?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|11|967-981

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.11, 2003-06, pp. : 967-981

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin‐converting enzyme 2–Angiotensin 1‐7/1‐9 system: novel promising targets for heart failure treatment

By  

Fundamental & Clinical Pharmacology, Vol. 32, Iss. 1, 2018-02 ,pp. : 14-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting Cardiomyocyte Ca2 Homeostasis in Heart Failure

By  

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 431-448

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Mitochondrial and Metabolism: Novel Targets for Heart Failure)

By  

Current Pharmaceutical Design, Vol. 22, Iss. 31, 2016-09 ,pp. : 4743-4743

Bentham Science Publishers

Access to resources Recommend Favorite

Ca2+-Sensitisers—A Promising Option to Treat Heart Failure?

By Brixius Klara   Hoyer Heike   Schwinger Robert  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 423-428

Springer Publishing Company

Access to resources Recommend Favorite

Dysregulation of Mfn2 and Drp-1 proteins in heart failure

By Givvimani Srikanth   Pushpakumar Sathnur   Veeranki Sudhakar   Tyagi Suresh C.  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 583-591

NRC Research Press

Access to resources Recommend Favorite